Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04014842 · ClinicalTrials.gov registry record · NA
RapidShock Post-Approval Study
A NA study, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- NA
- Development phase
- 2,756
- Enrollment target
NCT04014842 is a NA study that has completed, run by Zoll Medical Corporation. The registered enrollment target is 2,756 participants.
The verdict
NCT04014842, a NA study, has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,756 participants
- Enrollment target
Study Summary
Compare the performance of the Reconfirmation Analysis Mode algorithm to the performance goals recommended by the American Heart Association.
Interventions
- DEVICE RapidShock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,756 participants |
| Start Date | 2019-02-26 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04014842
The ClinicalTrials.gov registry entry for NCT04014842 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,756 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RapidShock is the first listed.
NCT04014842 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04014842 about?
NCT04014842 is a clinical study titled "RapidShock Post-Approval Study". Compare the performance of the Reconfirmation Analysis Mode algorithm to the performance goals recommended by the American Heart Association.
What is the current status of trial NCT04014842?
This trial is currently completed. It is a NA study. The enrollment target is 2,756 participants. The study started on 2019-02-26. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04014842?
The interventions under investigation include: RapidShock (DEVICE).
Who is sponsoring clinical trial NCT04014842?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.